The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features…
MANCHESTER, England, May 10, 2024 /PRNewswire/ — UK-headquartered, global Identity and Access Management (IAM) specialist, ProofID has won the Judge’s…